Jolanta Szelachowska
- Co-authors
- Rafał MatkowskiJan KornafelIwona GisterekAgnieszka HałońAdam MaciejczykB. SzynglarewiczPaweł SurowiakMichał Jeleń
- Topics
- Cancer Cells and Metastasis (7 papers)Angiogenesis and VEGF in Cancer (5 papers)Breast Cancer Treatment Studies (5 papers)
- Cited by
- OncologyCancer ResearchImmunology
In The Last Decade
Jolanta Szelachowska
31 papers receiving 497 citations
Peers
Comparison fields: 5 of 69
- Oncology 247
- Molecular Biology 208
- Immunology 117
- Cancer Research 113
- Pulmonary and Respiratory Medicine 61
Countries citing papers authored by Jolanta Szelachowska
This map shows the geographic impact of Jolanta Szelachowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanta Szelachowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanta Szelachowska more than expected).
Fields of papers citing papers by Jolanta Szelachowska
This network shows the impact of papers produced by Jolanta Szelachowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanta Szelachowska. The network helps show where Jolanta Szelachowska may publish in the future.
Co-authorship network of co-authors of Jolanta Szelachowska
This figure shows the co-authorship network connecting the top 25 collaborators of Jolanta Szelachowska. A scholar is included among the top collaborators of Jolanta Szelachowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolanta Szelachowska. Jolanta Szelachowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 10 | |
| 7 | 11 | |
| 8 | 46 | |
| 9 | 36 | |
| 10 | [Analysis of BCRP expression in breast cancer patients]. | 4 |
| 11 | Elevated nuclear YB1 expression is associated with poor survival of patients with early breast cancer. | 21 |
| 12 | 12 | |
| 13 | 43 | |
| 14 | 4 | |
| 15 | The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. | 96 |
| 16 | 28 | |
| 17 | 10 | |
| 18 | Prognostic significance of intracellular laminin and Her2/neu overexpression in non-small cell lung cancer. | 11 |
| 19 | Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. | 47 |
| 20 | Laminin, Her2/neu and Ki-67 as prognostic factors in non-small cell lung cancer. | 3 |
About Jolanta Szelachowska
Jolanta Szelachowska is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 34 papers that have together received 508 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Angiogenesis and VEGF in Cancer (5 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Oncology (247 citations), Cancer Research (113 citations) and Immunology (117 citations). Jolanta Szelachowska has collaborated with scholars based in Poland, Czechia and Greece. Frequent co-authors include Rafał Matkowski, Jan Kornafel, Iwona Gisterek, Agnieszka Hałoń, Adam Maciejczyk, B. Szynglarewicz, Paweł Surowiak, Michał Jeleń, Aleksandra Łacko and Marek Pudełko. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.